Skip to main content
Caplight Logo









Jenga Biosciences

Jenga Biosciences

Private
Carmel, IndianaHealthcare & Life Scienceshttps://www.jengabio.com/

Last Round

VC Round

Mar 1, 2024

Company Overview

Jenga Biosciences is a life sciences company that develops cancer treatments for veterinary use, specializing in pioneering immunotherapies for canine oncology.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

canine oncologycanine immunotherapyveterinary biotherapeuticsimmuno-oncologyveterinary oncologycheckpoint inhibitoranimal health biotechanchored cytokine therapyinterleukin-12IL-12caninized monoclonal antibodyPD-1 inhibitorcompanion animal healthdrug developmentin-licensing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Jenga Biosciences Comparables

Compare Jenga Biosciences with similar companies based on industry and business-model similarity.

Jenga Biosciences comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Torigen Pharmaceuticals, Inc.
83%
Vetigenics Inc.
82%
Animal Life Sciences
81%

Jenga Biosciences Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundMar 1, 2024

Jenga Biosciences Investors

Notable investors and investment history

Jenga Biosciences investors
InvestorRounds
Borealis VenturesVC Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2024

    Round led by Borealis Ventures

Jenga Biosciences Filings

Explore SEC and related filing metadata, where available.

Jenga Biosciences filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Jenga Biosciences's valuation, stock price, and market status.

Is Jenga Biosciences a public or private company?

Jenga Biosciences is a private company.

What is the current stock price of Jenga Biosciences?

Jenga Biosciences is a private company with no public stock price. No recent secondary market data is available.

How much is Jenga Biosciences worth (valuation)?

Valuation information for Jenga Biosciences is not publicly available.

Can I buy Jenga Biosciences stock?

Jenga Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Jenga Biosciences's last funding round?

Funding round information for Jenga Biosciences is not publicly available.

Who are the main investors in Jenga Biosciences?

Investor information for Jenga Biosciences is not publicly disclosed.

Will Jenga Biosciences IPO soon?

No public IPO plans have been announced for Jenga Biosciences.

How can I track Jenga Biosciences secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Jenga Biosciences's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCarmel, Indiana
Employee Range3
Year Founded2024
Last FundingMar 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?